Michaela Higgins and Gerry Hanna highlighting the unique strengths of Irish clinical trials – Cancer Trials Ireland
Cancer Trials Ireland shared a post on X:
” New Podcast episode. Join Michaela Higgins and Gerry Hanna as they share their journeys from global institutions back to Ireland, highlighting the unique strengths of Irish clinical trials.”
Jarushka Naidoo, Professor of Medical Oncology and Consultant Medical Oncologist at Beaumont RCSI Cancer Centre Dublin, also reshared the post:
“Well done Gerry Hanna and Cancer Trials Ireland. A great way to demystify how trials are developed and run and importance to patients.
Trials are the treatments of tomorrow.”
Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University. She currently serves as national lung cancer lead for Cancer Trials Ireland. She serves on several international guideline panels including ASCO and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials. She has received a number of grants including a young investigator award from the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC Communications Committee Chair.
More posts featuring Cancer Trials Ireland.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023